Sandoz Canada launches PrSandoz® Apremilast
PrSandoz® Apremilast is indicated for the treatment of psoriasis plaque (PsO), psoriatic arthritis (PsA) and oral ulcers associated with Behcet’s disease. PrSandoz® Apremilast is supported by the XPOSE® by Sandoz Patient Support Program (PSP), which …